1.
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the AT...
by Castle, Philip E, Dr
The lancet oncology, 2011, Vol.12 (9), p.880-890
2.
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detec...
by SASLOW, Debbie
American journal of clinical pathology, 2012, Vol.137 (4), p.516-542
3.
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
by Porras, Carolina
The lancet oncology, 2020, Vol.21 (12), p.1643-1652
4.
Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up st...
by Shing, Jaimie Z
The lancet oncology, 2022, Vol.23 (7), p.940-949
5.
Knowledge of Patients’ Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study
by Wright, Thomas C
American journal of clinical pathology, 2016, Vol.146 (3), p.391-398
6.
Are we insane? Observations on the idea of gynecologic screening cytology "productivity"
by Stoler, Mark H
American journal of clinical pathology, 2012, Vol.138 (6), p.766-769
7.
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population
by Castle, Philip E
American journal of clinical pathology, 2015, Vol.143 (1), p.126-133
8.
Detection of human papillomavirus 16, 18, and 45 in women with ASC-US cytology and the risk of cervical precancer: results from the CLEAR HPV study
by Castle, Phillip E
American journal of clinical pathology, 2015, Vol.143 (2), p.160-167
9.
The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors
by Cathro, Helen P
Human pathology, 2005, Vol.36 (2), p.195-201
10.
The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Cytology: Results From the ATHENA HPV Study
by STOLER, Mark H
American journal of clinical pathology, 2012, Vol.137 (2), p.295-303
11.
Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens
by Wright, Jr, Thomas C
American journal of clinical pathology, 2014, Vol.142 (1), p.43-50
12.
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica
by Gonzalez, Paula
Vaccine, 2015, Vol.33 (18), p.2141-2151
13.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
by Huh, Warner K
The Lancet (British edition), 2017, Vol.390 (10108), p.2143-2159
14.
Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives
by Bell, Debra A
Human pathology, 2004, Vol.35 (8), p.934-948
15.
Human Papillomavirus Oncogenic mRNA Testing for Cervical Cancer Screening
by Reid, Jennifer L
American journal of clinical pathology, 2015, Vol.144 (3), p.473-483
16.
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology: Results From the ATHENA HPV Study
by STOLER, Mark H
American journal of clinical pathology, 2011, Vol.135 (3), p.468-475
17.
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
by Frierson, Henry F
Human pathology, 2003, Vol.34 (6), p.605-609
18.
Patient Safety and the Next Generation of HPV DNA Tests
by KINNEY, Walter
American journal of clinical pathology, 2010, Vol.134 (2), p.193-199
19.
Special commentary: patient safety and the next generation of HPV DNA tests
by Kinney, Walter
American journal of clinical pathology, 2010, Vol.134 (2), p.193-199
20.
The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses : An ALTS report
by CASTLE, Philip E
American journal of clinical pathology, 2007, Vol.127 (5), p.805-815
